ABT-199 treatment of AML cells increases levels of MCL-1 protein, with resultant MCL-1 sequestration of the pro-apoptotic protein Bim, preventing the induction of apoptosis (38). This evidence concerns the gene MCL1 and acute myeloid leukemia.